Showing results (171-180 of 221) with videos related to
Sort By:
Pageof 23
Frontiers in Neuroscience|June 10, 2022
A Prebiotic Diet Alters the Fecal Microbiome and Improves Sleep in Response to Sleep Disruption in RatsSamuel J Bowers, Keith C Summa, Robert S Thompson, et al.Journal of Crohn'S & Colitis|June 4, 2019
IM-UNITI: Three-year Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn's DiseaseStephen B Hanauer, William J Sandborn, Brian G Feagan, et al.The Journal of Clinical Investigation|January 15, 2019
Neutrophil-induced genomic instability impedes resolution of inflammation and wound healingVeronika Butin-Israeli, Triet M Bui, Hannah L Wiesolek, et al.Inflammatory Bowel Diseases|March 21, 2013
Ciprofloxacin for the prevention of postoperative recurrence in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot studyHans H Herfarth, Jeffry A Katz, Stephen B Hanauer, et al.Gastroenterology|April 17, 2012
Abatacept for Crohn's disease and ulcerative colitisWilliam J Sandborn, Jean-Frederic Colombel, Bruce E Sands, et al.International Journal of Cancer|May 14, 2020
Association between inflammatory bowel disease and prostate cancer: A large-scale, prospective, population-based studyTravis J Meyers, Adam B Weiner, Rebecca E Graff, et al.Journal of Cellular Physiology|February 7, 2015
Environmental disruption of circadian rhythm predisposes mice to osteoarthritis-like changes in knee jointRanjan Kc, Xin Li, Robin M Voigt, et al.Biorxiv : the Preprint Server for Biology|January 7, 2026
Eosinophil-derived COX-2 protects against experimental colitis through the PGE2-IL-22 axisYang Yang, Constance L Atkins, Yuanyuan Fan, et al.The New England Journal of Medicine|November 4, 2005
Natalizumab induction and maintenance therapy for Crohn's diseaseWilliam J Sandborn, Jean Frédéric Colombel, Roberts Enns, et al.The New England Journal of Medicine|December 13, 2005
Infliximab for induction and maintenance therapy for ulcerative colitisPaul Rutgeerts, William J Sandborn, Brian G Feagan, et al.Pageof 23